Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

IGMC Shimla viral video row: Over 2,000 resident doctors on indefinite strike demanding revocation of doctors termination order

Chemists Launch Indefinite Strike Over Coldrif Tragedy, Demand Action Against Manufacturers Not Sellers

Parthika Patel9 Oct 2025 10:54 PM IST

Bhopal: The Chhindwara Chemist Association has launched an indefinite strike starting midnight to protest the sealing of five chemist shops linked to...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Parthika Patel9 Oct 2025 8:58 PM IST

Chennai: Officials from the Tamil Nadu Drugs Control Department uncovered horrific conditions at the Sresan Pharmaceuticals unit in Kancheepuram,...

ACB Nabs Government Medical Officer Over Rs 3.70 Lakh Bribe

Drugs Control Officials Caught Taking Rs 20,000 Bribe in Telangana

Parthika Patel8 Oct 2025 7:34 PM IST

Hyderabad: In an anti-corruption operation, the Telangana Anti-Corruption Bureau (ACB) has arrested three individuals in Karimnagar on Tuesday night...

Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg

Himachal, UP Join States Banning Coldrif Cough Syrup After MP Deaths

Parthika Patel8 Oct 2025 6:08 PM IST

New Delhi: Among various states cracking down on toxic cough syrups, the governments of Himachal Pradesh and Uttar Pradesh have now banned Coldrif...

Ajanta Pharma Told to Revise BE Study Protocol for Cilnidipine, Metoprolol FDC

Parthika Patel7 Oct 2025 8:30 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has reviewed the proposal by Ajanta Pharma...

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

Parthika Patel7 Oct 2025 6:21 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended granting permission to...

Show cause notices issued to 196 retail medical shops in Telangana

Toxic Coldrif Fallout: Tamil Nadu Govt Issues Show-Cause Notice to Sresan Pharma, License at Risk

Parthika Patel6 Oct 2025 7:51 PM IST

Chennai: The Tamil Nadu government has issued a show-cause notice to Sresan Pharmaceuticals, Kancheepuram, asking why its drug manufacturing license...

Pharma Education on Rise: Telangana Sees 96% B.Pharm Seat Fill-Up in TG EAPCET 2025

Maharashtra B.Pharm Admissions 2025: 29,166 Students Allotted Seats in First Round

Parthika Patel6 Oct 2025 7:33 PM IST

Mumbai: The much-awaited first round of Bachelor of Pharmacy (B.Pharm) admissions has finally been announced, bringing relief to thousands of aspiring...

Torrent Pharma Slapped with Rs 41.33 Crore GST Penalty for Alleged Erroneous Export Refunds

Torrent Pharma Slapped Rs 60.28 Lakh NPPA Notice for Alleged Overcharging

Parthika Patel5 Oct 2025 12:15 PM IST

New Delhi: Torrent Pharmaceuticals Limited has announced that it has received a demand notice from the National Pharmaceutical Pricing Authority...

MP Pharmacy Education Crisis: Over 16,000 B.Pharm, D.Pharm Seats Vacant Amid Low Admissions

Parthika Patel5 Oct 2025 11:30 AM IST

Bhopal: Alarm bells are ringing in Madhya Pradesh as more than 16,000 seats in B.Pharmacy and D.Pharmacy courses remain unfilled, raising urgent...

Zydus Lifesciences Secures CDSCO Panel Approval for Usnoflast Capsule Interaction Study

Parthika Patel5 Oct 2025 9:30 AM IST

New Delhi: The Subject Expert Committee (SEC) on Investigational New Drugs under CDSCO has recommended approval for Zydus Lifesciences Limited to...

MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab Tirumotecan

CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm

Parthika Patel4 Oct 2025 4:11 PM IST

New Delhi: The Subject Expert Committee (SEC) on Oncology under the Central Drugs Standard Control Organization (CDSCO) has raised critical concerns...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok